The response to neoadjuvant chemoradiotherapy with 5-fluorouracil in locally advanced rectal cancer patients: a predictive proteomic signature
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1559-0275
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
The response to neoadjuvant chemoradiotherapy with 5-fluorouracil in locally advanced rectal cancer patients: a predictive proteomic signature ; volume:15 ; number:1 ; day:13 ; month:4 ; year:2018 ; pages:1-16 ; date:12.2018
Clinical proteomics ; 15, Heft 1 (13.4.2018), 1-16, 12.2018
- Urheber
-
Chauvin, Anaïs
- Beteiligte Personen und Organisationen
-
Wang, Chang-Shu
Geha, Sameh
Garde-Granger, Perrine
Mathieu, Alex-Ane
Lacasse, Vincent
Boisvert, François-Michel
SpringerLink (Online service)
- DOI
-
10.1186/s12014-018-9192-2
- URN
-
urn:nbn:de:101:1-2018061704093542154690
- Rechteinformation
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
15.08.2025, 07:35 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Chauvin, Anaïs
- Wang, Chang-Shu
- Geha, Sameh
- Garde-Granger, Perrine
- Mathieu, Alex-Ane
- Lacasse, Vincent
- Boisvert, François-Michel
- SpringerLink (Online service)
Ähnliche Objekte (12)
Predictive value of proteomic markers for advanced rectal cancer with neoadjuvant chemoradiotherapy
Identification of proteomic markers for prediction of the response to 5-Fluorouracil based neoadjuvant chemoradiotherapy in locally advanced rectal cancer patients
Meta-analysis of neoadjuvant chemotherapy versus neoadjuvant chemoradiotherapy for locally advanced rectal cancer
Outcomes of neoadjuvant chemoradiotherapy in Japanese locally advanced rectal carcinoma patients
Usefulness of close surveillance for rectal cancer patients after neoadjuvant chemoradiotherapy
Factors influencing downstaging after neoadjuvant long-course chemoradiotherapy in rectal carcinoma
Comparing neoadjuvant long-course chemoradiotherapy with short-course radiotherapy in rectal cancer
Neoadjuvant chemoradiotherapy in rectal cancer : Are there new drug combinations on the horizon?
Genomic alterations in rectal tumors and response to neoadjuvant chemoradiotherapy: an exploratory study
“Watch and wait” strategy after neoadjuvant chemoradiotherapy in rectal cancer: opportunities and challenges
Loop ostomy following laparoscopic low anterior resection for rectal cancer after neoadjuvant chemoradiotherapy
The prognostic role of EZH2 expression in rectal cancer patients treated with neoadjuvant chemoradiotherapy
Predictive value of proteomic markers for advanced rectal cancer with neoadjuvant chemoradiotherapy
Identification of proteomic markers for prediction of the response to 5-Fluorouracil based neoadjuvant chemoradiotherapy in locally advanced rectal cancer patients
Meta-analysis of neoadjuvant chemotherapy versus neoadjuvant chemoradiotherapy for locally advanced rectal cancer
Outcomes of neoadjuvant chemoradiotherapy in Japanese locally advanced rectal carcinoma patients
Usefulness of close surveillance for rectal cancer patients after neoadjuvant chemoradiotherapy
Factors influencing downstaging after neoadjuvant long-course chemoradiotherapy in rectal carcinoma
Comparing neoadjuvant long-course chemoradiotherapy with short-course radiotherapy in rectal cancer
Neoadjuvant chemoradiotherapy in rectal cancer : Are there new drug combinations on the horizon?
Genomic alterations in rectal tumors and response to neoadjuvant chemoradiotherapy: an exploratory study
“Watch and wait” strategy after neoadjuvant chemoradiotherapy in rectal cancer: opportunities and challenges
Loop ostomy following laparoscopic low anterior resection for rectal cancer after neoadjuvant chemoradiotherapy
The prognostic role of EZH2 expression in rectal cancer patients treated with neoadjuvant chemoradiotherapy
Predictive value of proteomic markers for advanced rectal cancer with neoadjuvant chemoradiotherapy
Identification of proteomic markers for prediction of the response to 5-Fluorouracil based neoadjuvant chemoradiotherapy in locally advanced rectal cancer patients
Meta-analysis of neoadjuvant chemotherapy versus neoadjuvant chemoradiotherapy for locally advanced rectal cancer
Outcomes of neoadjuvant chemoradiotherapy in Japanese locally advanced rectal carcinoma patients
Usefulness of close surveillance for rectal cancer patients after neoadjuvant chemoradiotherapy
Factors influencing downstaging after neoadjuvant long-course chemoradiotherapy in rectal carcinoma
Comparing neoadjuvant long-course chemoradiotherapy with short-course radiotherapy in rectal cancer
Neoadjuvant chemoradiotherapy in rectal cancer : Are there new drug combinations on the horizon?
Genomic alterations in rectal tumors and response to neoadjuvant chemoradiotherapy: an exploratory study
“Watch and wait” strategy after neoadjuvant chemoradiotherapy in rectal cancer: opportunities and challenges
Loop ostomy following laparoscopic low anterior resection for rectal cancer after neoadjuvant chemoradiotherapy